HomeERNA • NASDAQ
add
Ernexa Therapeutics Inc
Previous close
$1.38
Day range
$1.26 - $1.40
Year range
$1.19 - $23.70
Market cap
9.90M USD
Avg Volume
58.67K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.50M | -48.78% |
Net income | -3.14M | 43.23% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.48M | 49.17% |
Effective tax rate | -0.10% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.32M | 66.86% |
Total assets | 7.58M | -83.69% |
Total liabilities | 3.14M | -94.29% |
Total equity | 4.44M | — |
Shares outstanding | 7.67M | — |
Price to book | 2.34 | — |
Return on assets | -98.91% | — |
Return on capital | -635.09% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.14M | 43.23% |
Cash from operations | -2.53M | -12.08% |
Cash from investing | — | — |
Cash from financing | 4.93M | 22,504.55% |
Net change in cash | 2.40M | 194.74% |
Free cash flow | -6.87M | -256.19% |
About
Founded
2018
Headquarters
Website
Employees
6
